Rapid Micro Biosystems (RPID) Net Margin Growth (1y) (2021 - 2026)
Rapid Micro Biosystems (RPID) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -314.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 123.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -296.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1,132.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 656.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -430.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Rapid Micro Biosystems | 77.24 Mn | 54.29 Mn | 371,000.00 | -2,207.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,207.00 |
| Dec 31, 2025 | 685.00 |
| Sep 30, 2025 | 212.00 |
| Jun 30, 2025 | 2,677.00 |
| Mar 31, 2025 | 8,110.00 |
| Dec 31, 2024 | 5,868.00 |
| Sep 30, 2024 | 6,902.00 |
| Jun 30, 2024 | 9,015.00 |
| Mar 31, 2024 | 3,838.00 |
| Dec 31, 2023 | 19,972.00 |
| Sep 30, 2023 | 12,684.00 |
| Jun 30, 2023 | 5,891.00 |
| Mar 31, 2023 | 8,308.00 |
| Dec 31, 2022 | -9,558.00 |
| Sep 30, 2022 | 2,090.00 |
| Jun 30, 2022 | -11,237.00 |
| Mar 31, 2022 | 12,757.00 |
| Dec 31, 2021 | -2,054.00 |
| Sep 30, 2021 | -16,158.00 |
| Jun 30, 2021 | 20,850.00 |